The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
History is no stranger to global pandemics. Greek soldiers were hit with a deadly influenza in 430 B.C.E., the earliest recorded pandemic. Europe and Asia were decimated by the Black Death in the 1300s; cholera ran rampant in the 19th century; and HIV/AIDS afflicted modern times. Each has taught us something about how to manage […]
Webinar with Ron Brachman, Server Ertem, Rebecca Brachman, and Tomer Morad What happens when industry intersects academia? Join Ron Brachman, director of the Joan & Irwin Jacobs Technion-Cornell Institute housed at Cornell Tech in New York City, for this special webinar. Learn about the unique collaboration that has led to 28 startups incubated at the Jacobs Institute’s Runway Startup Postdoc Program, and the many Runway Fellows who tackled the coronavirus pandemic. Runway Fellows Server A. Ertem and Rebecca Anne Brachman discuss developing a test to determine if a patient has developed sufficient immunity against the coronavirus to safely return to…
Technion Professor Josué Sznitman and his team have developed an innovative pulmonary treatment for treating Acute Respiratory Distress Syndrome (ARDS), which is recognized as the leading cause of mortality in COVID-19 patients. To date, there is no existing therapy to treat ARDS patients. These patients undergo assisted ventilation and oxygenation, oftentimes under intubation, in intensive care units. One of the hallmarks of ARDS is damage to pulmonary surfactant (the liquid that coats the surface of alveoli in the lungs). Surfactant has many roles, but perhaps most importantly it reduces the forces required for breathing. While research is ongoing to understand…
Professor Ezri Tarazi, chair of the Industrial Design Program and head of the Design-Tech Lab at the Technion – Israel Institute of Technology, together with doctors at the Clinical Research Institute at Rambam Health Care Campus, have developed a breakthrough device that dramatically improves the efficacy of protective masks worn by COVID-19 medical staff everywhere. Medical staff worldwide report that overheating and foggy glasses make it difficult for staff to care for COVID-19 patients. Body temperature often causes condensation to build up inside protective gear, which causes masks to fog up and makes it difficult for medical staff to see…
Webinar with Professor Yaron Fuchs Could insights about cell death lead to better ways to contain viral infections, and serve as the basis for new drug development? According to Technion alumnus and Assistant Professor Yaron Fuchs, they just might. While scientists have long studied stem cell rejuvenation, Prof. Fuchs had the courage and insight to follow a new direction. Looking at the flip side of stem cell renewal — death, he broke new, unexplored ground that is leading to novel insights and strategies in tissue regeneration, including recovery processes in the intestines, hair growth, treatments for cancer and other diseases,…
Technion Professor Noam Adir’s creativity knows no bounds. He has invented spinach-powered electricity cells, as well as technology to harvest energy from photosynthetic bacteria found in ponds. In this webinar, Prof. Adir talks about his equally exciting biomedical research, studying proteins that can serve as targets for novel drug development. He and his research team […]
Webinar with Professor Asya Rolls Why is it that at least one-third of patients in medical trials get better with placebos? Many scientists are connecting the dots. Neuroscience has shown that every thought and emotion triggers specific brain activity that can be measured and manipulated. In this special webinar, Technion Professor Asya Rolls talks about her research in understanding how one’s positive thoughts and expectations may impact the body’s ability to fight off germs. In one study, she showed that the release of the so-called “feel-good neurotransmitter” dopamine disabled tumor-promoting cells in the immune system of mice, allowing them to…
A Webinar with Professor Avi Schroeder Whether it is the coronavirus behind the global COVID-19 pandemic, or one that causes a devastating disease in shrimp, all viruses require certain proteins in order to pass from one cell to another. Stopping the production of those proteins will effectively stop the virus. In this special webinar, Technion Professor Avi Schroeder talks about how synthesizing a molecule called siRNA, and using it to replace naturally occurring RNA molecules, has proven effective in stopping the highly destructive white spot virus from passing from one cell to another in shrimp. According to Prof. Schroeder, it…
The World Health Organization (WHO) has named vaccine hesitancy — the reluctance or refusal to vaccinate despite the availability of vaccines — as one of the top 10 threats to global health. Online misinformation may compound the problem. Yet despite this risk, little research attention has been paid to understanding how individuals seek vaccine information online and evaluate its trustworthiness.
Researchers at the Technion and Rambam Health Care Campus have successfully tested a method that will dramatically increase the current COVID-19 testing capacity using existing available resources. This method, known as pooling, enables simultaneous testing of dozens of samples. Its implementation has the potential to greatly accelerate the rate of testing and detection of the population’s COVID-19-infected patients. The trial was completed in a matter of days thanks to the support of the Ministry of Health and the close collaboration between the Technion and Rambam. Testing for COVID-19 is currently being conducted in Israel with the focus on people with…
Researchers at the Technion, the Rambam Healthcare Campus (Rambam Medical Center), and colleagues at the McEwen Stem Cell Institute at the University Health Network in Toronto have succeeded in producing 3D engineered cardiac tissues from embedded chamber-specific heart cells (atrial and ventricular cells) derived from human stem cells. The tissues, which simulate heart tissues of the atrium (auricle, or the upper chamber of the heart through which blood enters the ventricles) or the ventricles, will serve in the near future for personalizing medications for cardiac patients and developing new drugs to treat them. In the more distant future, the technology…
Research by Professor Yuval Shaked of the Technion presents new ways to curb the development of anti-cancer therapy resistance, a phenomenon that is detrimental to the efficacy of existing cancer treatments. His research was recently summarized in a published article in Nature Reviews Cancer. Anti-cancer therapy resistance: A devastating challenge Although the initial cancer treatment phase is often successful, many patients become resistant to anti-cancer therapies, characterized by tumor relapse and/or spread. The majority of studies have so far focused on investigating the basis of resistance as a result of tumor-related changes. But over the last decade, Prof. Shaked and…